Fig. 3.
Severity and duration of average pain reported by PBSC donors.
This shows the severity (x-axis) and duration through the day (y-axis) of average pain reported by PBSC donors on day −1 (day 5 of filgrastim administration). Points in the upper-right quadrant correspond to donors' exceeding the pain scale midpoints for both severity and duration.